"We in big pharma should never take for granted our right to exist; our business model is not written into any country’s constitution. So we should be turning up to work every day with the mindset that we are earning the right to exist. We are earning it by meeting the expectations of society. When you start to think like this, you see the world differently."
Andrew Witty - CEO, GlaxoSmithKline
Report Pharma Futures 3: Emerging Opportunities
Explores the link between sustainable pharmaceutical business models and global health outcomes in emerging markets
Established in 1987, SustainAbility is a strategy consultancy and think tank working with senior corporate decision makers to achieve transformative leadership on the sustainability agenda. We offer a range of services and undertake advocacy in order to create financial value at the same time as addressing environmental, social and governance issues in an integrated manner.